Skip to main content
生物谷 logo

生物谷 — Investor Relations & Filings

Ticker · 920266 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2022-06-29 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920266

About 生物谷

https://www.bioon.com/

Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.

Recent filings

Filing Released Lang Actions
第四届董事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the fifth meeting of the fourth board of directors of Yunnan Shengwu Gu Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and changes in senior management positions. The content focuses on board decisions and management changes rather than financial results or reports. There is no indication of financial statements or detailed financial analysis. The document is not a full annual or interim report, nor is it an earnings release or audit report. It is not a proxy statement or voting results announcement for shareholders. The primary focus is on board and management information, specifically changes in senior management and board resolutions. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short (1795 characters), consistent with a meeting resolution announcement rather than a full report.
2022-06-29 Chinese
关于控股股东、实际控制人未完成承诺及董事会拟采取措施的提示性公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company regarding the failure of its controlling shareholder and actual controller to fulfill a financial commitment, specifically the non-repayment of funds occupied by the controlling shareholder. It details the background, current status, pledged assets, risks, and proposed measures to address the issue. The document is an announcement of a corporate governance and financial issue related to shareholder commitments and board actions, but it is not a full financial report, audit report, or earnings release. It does not contain financial statements or detailed financial data. It is also not a regulatory certification or a simple report publication announcement. The content fits best under Regulatory Filings (RNS) as it is a regulatory disclosure about a material event affecting the company but does not fit other more specific categories.
2022-06-29 Chinese
关于控股股东非经营性资金占用进展情况的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the progress of non-operating fund occupation by its controlling shareholder. It details amounts of funds occupied and repaid, pledges of assets as guarantees, and planned measures to resolve the issue. The document is a regulatory disclosure about related-party transactions and fund occupation issues, not a financial report, earnings release, or management discussion. It is a typical regulatory announcement informing shareholders and the market about a material issue affecting the company. The document length is short (1422 characters), and it is not a report itself but a disclosure announcement. Therefore, it fits best under Regulatory Filings (RNS).
2022-06-29 Chinese
关于股东签订股权转让意向协议和投票权委托协议暨控制权拟发生变更的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a detailed announcement regarding a change in the actual controlling shareholder of the company through a share transfer agreement and voting rights entrustment agreement. It includes specifics about the share transfer, voting rights delegation, parties involved, agreement terms, and regulatory compliance. The document does not contain financial statements or quarterly/yearly financial results but focuses on ownership and control changes. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels and control changes. The document length (8725 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive disclosure about shareholding changes and control. Therefore, the appropriate classification is MRQ with high confidence.
2022-06-29 Chinese
高级管理人员任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of senior management personnel, specifically the appointment of a new board secretary and financial officer. It includes details about the appointment process, qualifications, and independent directors' opinions. There is no financial data, earnings information, or report content. The document is clearly about management changes, fitting the category of Board/Management Information (MANG). The document length is short and focused solely on management appointments, confirming it is not a full report or announcement of a report publication.
2022-06-29 Chinese
独立董事关于第四届董事会第五次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at a board meeting, including the review of proposals related to the controlling shareholder's commitments and changes in senior management. It references the company's articles, laws, and internal rules, and provides independent directors' approval opinions. There is no financial data, no report publication, no voting results, and no regulatory certification. The content is focused on board/management matters, specifically management changes and board decisions. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report but an opinion on board matters.
2022-06-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.